Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Málaga
Clinical trial register · Spain

Clinical Trials in Málaga, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 188 Madrid 183 Seville 71 Málaga 66 Valencia 60
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca66 Janssen Research & Development, LLC30 Merck Sharp & Dohme LLC29 Hoffmann-La Roche28 Bristol-Myers Squibb26 Clear sponsor filter
Site location
Barcelona188 Madrid183 Seville71 Málaga66 Valencia60
All 103 locations
Target enrolment
to

Trials with a site in Málaga

66 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
AstraZeneca
Phase 3
7,000
Badajoz, Barcelona, Burgos, Córdoba, Granada, Madrid, Majadahonda, Málaga
2026-08-21
Recruiting
AstraZeneca
Phase 3
1,500
A Coruña, Alzira, Barcelona, Ferrol, Lleida, Málaga, Oviedo, Segovia
2026-08-20
Recruiting
AstraZeneca
Phase 3
900
Barcelona, Ferrol, Lleida, Madrid, Majadahonda, Málaga, Santander, Seville
2026-07-06
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Valencia
2026-06-11
Active, closed
AstraZeneca
Phase 2
326
Barcelona, Jaén, L'Hospitalet de Llobregat, Majadahonda, Málaga, Pamplona, Salamanca, Valencia
2026-06-11
Recruiting
AstraZeneca
Phase 3
670
Barcelona, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga, Santiago de Compostela
2026-05-04
Recruiting
AstraZeneca
Phase 2
320
Barcelona, Málaga, Sabadell, Santiago de Compostela, Valencia
2025-12-15
Recruiting
AstraZeneca
Phase 3
400
A Coruña, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Seville, Zaragoza
2025-10-31
Active, closed
AstraZeneca
Phase 3
68
A Coruña, Badajoz, Barakaldo, Barcelona, Madrid, Málaga, Oviedo, Santander
2025-09-15
Recruiting
AstraZeneca
Phase 2
278
A Coruña, Madrid, Manresa, Málaga, Santander, Valencia
2025-08-07
Recruiting
AstraZeneca
Phase 3
700
Barcelona, Girona, Madrid, Majadahonda, Málaga, Oviedo, Sabadell, Santander
2025-08-06
Recruiting
AstraZeneca
Phase 3
800
Badalona, Barcelona, Córdoba, El Palmar (Murcia), L'Hospitalet de Llobregat, Madrid, Málaga, Oviedo
2025-08-01
Recruiting
AstraZeneca
Phase 2
100
Barcelona, Elche, Madrid, Málaga, Ourense, Oviedo, Santander, Valencia
2025-07-17
Recruiting
AstraZeneca
Phase 2
987
Benalmádena, Granollers, Madrid, Málaga, Mérida, Pozuelo de Alarcón, Santander
2025-06-27
Recruiting
AstraZeneca
Phase 3
15,100
A Coruña, Alicante, Barcelona, Cáceres, Huelva, Madrid, Málaga, Murcia
2025-06-04
Recruiting
AstraZeneca
Phase 2
540
Barcelona, Madrid, Málaga, Mérida, Patraix, Santander
2025-03-26
Recruiting
AstraZeneca
Phase 3
990
Barakaldo, Barcelona, Granada, Madrid, Málaga, Palma de Mallorca, Pamplona, Seville
2025-03-18
Recruiting
AstraZeneca
Phase 3
11,300
A Coruña, Barcelona, Córdoba, L'Hospitalet de Llobregat, Madrid, Málaga, Sant Joan Despí, Santiago(A Coruña)
2025-03-14
Recruiting
AstraZeneca
Phase 2
80
Barcelona, Madrid, Málaga, Pamplona, Santander, Valencia
2025-03-12
Recruiting
AstraZeneca
Phase 3
5,000
A Coruña, Almería, Badalona, L'Hospitalet de Llobregat, Majadahonda, Málaga, Palma deMallorca, Pamplona
2025-03-03
Recruiting
AstraZeneca
Phase 3
744
A Coruña, Barakaldo, Barcelona, El Palmar, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga
2024-10-04
Active, closed
AstraZeneca
Phase 2
194
A Coruña, Alcorcón, Barcelona, Madrid, Málaga, Pamplona, Santander, Santiago de Compostela
2024-08-27
Recruiting
AstraZeneca
Phase 3
620
Barcelona, Madrid, Málaga, Santander
2024-08-12
Recruiting
AstraZeneca
Phase 3
788
A Coruña, Barcelona, Cáceres, Granada, L'Hospitalet de Llobregat, Madrid, Málaga, Pamplona
2024-08-01
Active, closed
AstraZeneca
Phase 3
2,554
A Coruña, Almería, Badalona, L'Hospitalet de Llobregat, Lugo, Madrid, Málaga, Palma deMallorca
2024-03-29
Recruiting
AstraZeneca
Phase 3
100
Esplugues de Llobregat, Madrid, Málaga, Santiago de Compostela, Valencia
2024-03-14
Active, closed
AstraZeneca
Phase 3
760
Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Pamplona, Santander
2023-12-04
Active, closed
AstraZeneca
Phase 3
314
A Coruña, Barcelona, Madrid, Málaga, Valencia
2023-11-08
Active, closed
AstraZeneca
Phase 3
895
Alicante, Barcelona, Bilbao (Vizcaya), Madrid, Málaga, Palma
2023-10-24
Recruiting
PICAROS - Acalabrutinib RWE on 1L CLL in Spain
NCT05999877Chronic Lymphocytic Leukemia
AstraZeneca
Observational
315
Almería, Córdoba, Granada, Jaén, Marbella, Málaga, Seville, Zaragoza
2023-07-11
Recruiting
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
NCT05797168Ovarian Cancer, Lung Adenocarcinoma, Endometrial Cancer, Lung Squamous Cell Carcinoma
DrugsPalacaparib·Torvutatug samrotecan·Saruparib·Paraplatin
AstraZeneca
Phase 1/2
622
Barcelona, Madrid, Málaga
2023-06-05
Recruiting
AstraZeneca
Phase 3
3,527
Barcelona, Madrid, Majadahonda, Málaga, Ourense, Palma de Mallorca, Pamplona, Santander
2022-12-13
Active, closed
AstraZeneca
Phase 3
1,174
Barcelona, Bilbao (Vizcaya), Elche(Alicante), Madrid, Málaga, Palma de Mallorca, Toledo, Valencia
2022-11-28
Active, closed
AstraZeneca
Phase 3
594
A Coruña, Barcelona, Castellon, Córdoba, Hospitalet deLlobregat, Madrid, Málaga, Ourense
2022-09-15
Recruiting
AstraZeneca
Phase 2
454
Barcelona, Córdoba, Madrid, Málaga, Pamplona, Seville
2022-09-06
Active, closed
AstraZeneca
Phase 2
194
Barcelona, Madrid, Málaga, Pamplona, Pozuelo de Alarcón
2022-08-11
Active, closed
AstraZeneca
Phase 3
341
Badajoz, Badalona, Barcelona, Córdoba, Girona, Madrid, Majadahonda, Málaga
2022-08-03
Recruiting
AstraZeneca
Phase 1/2
695
A Coruña, Barcelona, Málaga, Pozuelo de Alarcón, Sant Cugat del Vallès, Seville
2022-06-24
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Barcelona, Madrid, Málaga, Santiago de Compostela, Seville
2022-05-23
Active, closed
AstraZeneca
Phase 3
644
Barcelona, Granada, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga, Santiago de Compostela, Seville
2022-05-16
Recruiting
AstraZeneca
Phase 2
630
A Coruña, Alicante, Barcelona, Córdoba, Madrid, Majadahonda, Málaga, Reus
2022-04-14
Active, closed
AstraZeneca
Phase 3
1,035
Barcelona, Córdoba, Lugo, Madrid, Málaga, Sabadell, Seville
2022-03-25
Active, closed
AstraZeneca
Phase 3
390
Barcelona, Málaga, Valencia, Vigo, Zaragoza
2022-02-21
Active, closed
AstraZeneca
Phase 3
148
A Coruña, Barcelona, Córdoba, Madrid, Majadahonda, Málaga, Pamplona, Seville
2021-10-28
Active, closed
AstraZeneca
Phase 3
454
L'Hospitalet de Llobregat, Madrid, Málaga, Valencia
2021-10-28
Active, closed
AstraZeneca
Phase 3
732
A Coruña, Barcelona, Bilbao (Vizcaya), Huelva, L'Hospitalet de Llobregat, Madrid, Málaga, Seville
2021-10-18
Recruiting
AstraZeneca
Phase 1/2
460
Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Pamplona
2021-10-18
Active, closed
AstraZeneca
Phase 3
98
Alicante, Barcelona, Córdoba, León, Madrid, Málaga, Murcia, Oviedo
2021-09-12
Active, closed
AstraZeneca
Phase 3
315
A Coruña, Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Murcia, Sant Joan Despí
2021-06-30
Active, closed
AstraZeneca
Phase 3
893
Barcelona, Granada, Lleida, Madrid, Málaga, Pamplona, Santiago de Compostela
2021-05-10
Active, closed
AstraZeneca
Phase 3
1,371
Barcelona, Jaén, Lleida, Madrid, Málaga, Pamplona, Santander, Seville
2021-01-28
Active, closed
AstraZeneca
Phase 3
358
Barcelona, Madrid, Majadahonda, Málaga
2020-12-16
Active, closed
AstraZeneca
Phase 3
957
Barcelona, Madrid, Málaga, Ourense, Santander, Seville, Valencia
2020-11-17
Active, closed
AstraZeneca
Phase 1/2
702
Barcelona, Madrid, Málaga, Pozuelo de Alarcón, Seville
2020-11-12
Active, closed
AstraZeneca
Phase 3
923
Badalona, Barcelona, Hospitalet deLlobregat, Jaén, Madrid, Málaga, Seville, Valencia
2019-06-25
Active, closed
AstraZeneca
Phase 3
724
Badajoz, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, San Sebastián, Santiago de Compostela, Seville
2019-03-06
Active, closed
AstraZeneca
Phase 2
367
Córdoba, Donostia / San Sebastian, Madrid, Málaga, Valencia, Zaragoza
2019-01-09
Active, closed
AstraZeneca
Phase 3
825
Alicante, Barcelona, Donostia / San Sebastian, Madrid, Málaga, Oviedo, Pamplona, Santiago de Compostela (A Coruña)
2018-12-06
Active, closed
AstraZeneca
Phase 3
895
Barcelona, Girona, Madrid, Málaga, Seville
2018-10-31
Active, closed
AstraZeneca
Phase 3
1,246
Barcelona, Lugo, Madrid, Málaga, Santander, Seville
2018-09-27
Active, closed
AstraZeneca
Phase 3
216
Barcelona, Madrid, Málaga, San Sebastián, Seville, Valencia
2018-07-19
Active, closed
AstraZeneca
Phase 3
1,018
Badajoz, Barcelona, Elche(Alicante), Madrid, Málaga, Oviedo, Pamplona, Pozuelo de Alarcón
2018-05-14
Active, closed
AstraZeneca
Phase 2
154
Barcelona, Madrid, Málaga, Santiago de Compostela
2018-03-16
Active, closed
AstraZeneca
Phase 3
682
A Coruña, Barcelona, Donostia / San Sebastian, Elche, Las Palmas de Gran Canaria, Madrid, Majadahonda, Málaga
2015-10-21
Active, closed
AstraZeneca
Phase 3
510
Barcelona, Madrid, Málaga, Seville, Vigo(Pontevedra), Zaragoza
2013-09-25
Active, closed
AstraZeneca
Phase 3
736
A Coruña, Madrid, Málaga, Oviedo, Salamanca, Seville
2005-02-13
Rows per page Showing 1–66 of 66
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/m-laga

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 66 of those studies with a site in Málaga that also match the filters currently applied.

How many clinical trials are recruiting in Málaga?

29 of the 66 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 37 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Málaga), 66 studies
PhaseStudiesRecruitingShare
Phase 3461669.7%
Phase 214921.2%
Phase 1/2436.1%
Observational213%

Most active sponsors

Lead sponsors with the most studies (Málaga)
Lead sponsorStudiesRecruiting
AstraZeneca6629
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.